Literature DB >> 15768203

Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.

Paola Sandroni1, Tonette L Opfer-Gehrking, Wolfgang Singer, Phillip A Low.   

Abstract

We report the result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension. Aim of the study was to evaluate self-reported efficacy and patients' satisfaction with the medication. Most patients were very satisfied with the medication and chose to continue it.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15768203     DOI： 10.1007/s10286-005-0225-3

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


  8 in total

1.  Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.

Authors:  P A Low; J L Gilden; R Freeman; K N Sheng; M A McElligott
Journal:  JAMA       Date:  1997-04-02       Impact factor: 56.272

2.  Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia.

Authors:  G Jacob; J R Shannon; B Black; I Biaggioni; R Mosqueda-Garcia; R M Robertson; D Robertson
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

3.  Association between supine hypertension and orthostatic hypotension in autonomic failure.

Authors:  David S Goldstein; Sandra Pechnik; Courtney Holmes; Basil Eldadah; Yehonatan Sharabi
Journal:  Hypertension       Date:  2003-06-30       Impact factor: 10.190

4.  Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension.

Authors:  W Singer; T L Opfer-Gehrking; B R McPhee; M J Hilz; A E Bharucha; P A Low
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

5.  Mineralocorticoid-induced hypertension in patients with orthostatic hypotension.

Authors:  A V Chobanian; L Volicer; C P Tifft; H Gavras; C S Liang; D Faxon
Journal:  N Engl J Med       Date:  1979-07-12       Impact factor: 91.245

6.  The hypertension of autonomic failure and its treatment.

Authors:  J Shannon; J Jordan; F Costa; R M Robertson; I Biaggioni
Journal:  Hypertension       Date:  1997-11       Impact factor: 10.190

7.  Gastrointestinal motility disturbances in patients with orthostatic hypotension.

Authors:  M Camilleri; J R Malagelada; V Stanghellini; R D Fealey; S G Sheps
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

8.  A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension.

Authors:  R A Wright; H C Kaufmann; R Perera; T L Opfer-Gehrking; M A McElligott; K N Sheng; P A Low
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910
  8 in total
  8 in total

1.  Pyridostigmine in the treatment of orthostatic hypotension.

Authors:  Jean-Michel Senard
Journal:  Clin Auton Res       Date:  2005-12       Impact factor: 4.435

2.  Acetylcholinesterase inhibition and orthostatic hypotension.

Authors:  Vincenzo Provitera; Maria Nolano; Angela Pagano
Journal:  Clin Auton Res       Date:  2006-04       Impact factor: 4.435

Review 3.  Management of neurogenic orthostatic hypotension in patients with autonomic failure.

Authors:  Christoph Schroeder; Jens Jordan; Horacio Kaufmann
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

4.  Ion channels PIEZOs identified as the long-sought baroreceptor mechanosensors for blood pressure control, and other updates on autonomic research.

Authors:  Mitchell G Miglis; Srikanth Muppidi
Journal:  Clin Auton Res       Date:  2019-01-02       Impact factor: 4.435

5.  Autonomic mechanisms and therapeutic implications of postural diabetic cardiovascular abnormalities.

Authors:  Rohit R Arora; Robert J Bulgarelli; Samanwoy Ghosh-Dastidar; Joseph Colombo
Journal:  J Diabetes Sci Technol       Date:  2008-07

6.  Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug?

Authors:  Tatsuya Yamamoto; Ryuji Sakakibara; Yoshitaka Yamanaka; Tomoyuki Uchiyama; Masato Asahina; Zhi Liu; Takashi Ito; Yu Koyama; Yusuke Awa; Kaori Yamamoto; Mika Kinou; Takamichi Hattori
Journal:  Clin Auton Res       Date:  2006-06-21       Impact factor: 5.625

7.  Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.

Authors:  Brent P Goodman; Fiona Gupta
Journal:  Clin Auton Res       Date:  2017-06-19       Impact factor: 4.435

Review 8.  Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms.

Authors:  Sabine Eschlböck; Gregor Wenning; Alessandra Fanciulli
Journal:  J Neural Transm (Vienna)       Date:  2017-10-22       Impact factor: 3.575
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.